Technical aspects of the mouse aortocaval fistula
- PMID: 23892387
- PMCID: PMC3732098
- DOI: 10.3791/50449
Technical aspects of the mouse aortocaval fistula
Abstract
Technical aspects of creating an arteriovenous fistula in the mouse are discussed. Under general anesthesia, an abdominal incision is made, and the aorta and inferior vena cava (IVC) are exposed. The proximal infrarenal aorta and the distal aorta are dissected for clamp placement and needle puncture, respectively. Special attention is paid to avoid dissection between the aorta and the IVC. After clamping the aorta, a 25 G needle is used to puncture both walls of the aorta into the IVC. The surrounding connective tissue is used for hemostatic compression. Successful creation of the AVF will show pulsatile arterial blood flow in the IVC. Further confirmation of successful AVF can be achieved by post-operative Doppler ultrasound.
Similar articles
-
Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis.J Vis Exp. 2019 Jul 11;(149). doi: 10.3791/59540. J Vis Exp. 2019. PMID: 31355803
-
Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium.J Vis Exp. 2016 Mar 4;(109):e53905. doi: 10.3791/53905. J Vis Exp. 2016. PMID: 26967580 Free PMC article.
-
A mouse model of stenosis distal to an arteriovenous fistula recapitulates human central venous stenosis.JVS Vasc Sci. 2020;1:109-122. doi: 10.1016/j.jvssci.2020.07.003. Epub 2020 Jul 28. JVS Vasc Sci. 2020. PMID: 33543148 Free PMC article.
-
Vascular access animal models used in research.Ann Anat. 2019 Sep;225:65-75. doi: 10.1016/j.aanat.2019.06.002. Epub 2019 Jul 4. Ann Anat. 2019. PMID: 31279868
-
Innovative surgical approaches to maximize arteriovenous fistula creation.Semin Vasc Surg. 2007 Sep;20(3):141-7. doi: 10.1053/j.semvascsurg.2007.07.005. Semin Vasc Surg. 2007. PMID: 17884614 Review.
Cited by
-
Endothelial Cell TGF-β (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency.Arterioscler Thromb Vasc Biol. 2022 Jul;42(7):868-883. doi: 10.1161/ATVBAHA.122.317676. Epub 2022 May 5. Arterioscler Thromb Vasc Biol. 2022. PMID: 35510552 Free PMC article.
-
Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):e160-e174. doi: 10.1161/ATVBAHA.120.315875. Epub 2021 Jan 21. Arterioscler Thromb Vasc Biol. 2021. PMID: 33472405 Free PMC article.
-
Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula Patency.Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):754-764. doi: 10.1161/ATVBAHA.119.312417. Arterioscler Thromb Vasc Biol. 2019. PMID: 30786746 Free PMC article.
-
Temporal regulation of venous extracellular matrix components during arteriovenous fistula maturation.J Vasc Access. 2015 Mar-Apr;16(2):93-106. doi: 10.5301/jva.5000290. Epub 2014 Sep 8. J Vasc Access. 2015. PMID: 25262757 Free PMC article.
-
Sustained tenascin-C expression drives neointimal hyperplasia and promotes aortocaval fistula failure.Am J Physiol Heart Circ Physiol. 2025 Jun 1;328(6):H1147-H1167. doi: 10.1152/ajpheart.00661.2024. Epub 2025 Apr 17. Am J Physiol Heart Circ Physiol. 2025. PMID: 40247455 Free PMC article.
References
-
- Allon M. Current management of vascular access. Clinical Journal of the American Society of Nephrology. 2007;2(4):786–800. - PubMed
-
- Dixon BS. Why don't fistulas mature? Kidney International. 2006;70(8):1413–1422. - PubMed
-
- Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. Journal of Nephrology. 2007;20(2):150–163. - PubMed
-
- Kudo FA, Muto A, et al. Venous identity is lost but arterial identity is not gained during vein graft adaptation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27(7):1562–1571. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources